Worth a repost. Some folks are not paying atte
Post# of 148169
(Total Views: 614)
Posted On: 03/05/2021 10:22:27 PM
Worth a repost.
Some folks are not paying attention to the FDA. Here is a summary of FDA Director Janet Woodcock’s comments about S/C Treatments and drugs:
- The FDA acknowledged that normal P-Factor is not the bar they want to set to evaluate Treatments for S/C during a pandemic.
- If any Treatment shows good improvement over SOC for S/C patients, the FDA will be inclined to offer an EUA and continue evaluating said Treatment for either full approval or discontinuance of the EUA.
- S/C patients have no choice. Any Treatment that is SAFE and gives them a better chance of survival WILL receive an EUA as the alternative is death.
- The FDA will be looking to pair up viable drugs to improve that chance of survival through partnerships.
Some folks are not paying attention to the FDA. Here is a summary of FDA Director Janet Woodcock’s comments about S/C Treatments and drugs:
- The FDA acknowledged that normal P-Factor is not the bar they want to set to evaluate Treatments for S/C during a pandemic.
- If any Treatment shows good improvement over SOC for S/C patients, the FDA will be inclined to offer an EUA and continue evaluating said Treatment for either full approval or discontinuance of the EUA.
- S/C patients have no choice. Any Treatment that is SAFE and gives them a better chance of survival WILL receive an EUA as the alternative is death.
- The FDA will be looking to pair up viable drugs to improve that chance of survival through partnerships.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼